(HealthDay)—A natural cholesterol-lowering supplement called red yeast rice could pose the same health risks to users as statin drugs, a new study contends.
Jan 24, 2017
0
0
Red yeast rice supplement has the potential to cause liver damage, warn doctors in the journal BMJ Case Reports, after a 64-year old woman developed acute liver injury after six weeks of taking the supplement.
Mar 25, 2019
0
2
DEAR MAYO CLINIC: As I have gotten older, doctors have placed me on more medications, such as for blood pressure and cholesterol. Also, as I age, I have chosen to take some supplements that are supposed to improve my memory, ...
Oct 14, 2021
0
4
A Japanese drugmaker whose dietary supplements are at the center of a growing health scare reported on Thursday two more deaths potentially related to its tablets.
Mar 28, 2024
0
0
Your GP says you have high cholesterol. You've six months to work on your diet to see if that'll bring down your levels, then you'll review your options.
Sep 15, 2023
0
4
A Japanese drugmaker said on Friday it is investigating five deaths potentially linked to dietary supplements meant to lower cholesterol and apologized for the "anxiety and fear" it had caused.
Mar 29, 2024
0
0
A Japanese drugmaker said Tuesday it is investigating one death from kidney dysfunction potentially linked to health supplements recalled last week by the firm.
Mar 26, 2024
0
0
Red yeast rice (RYR) is contained in dietary supplements that are often used by patients with high cholesterol, and it is often proposed as an alternative therapy in those who experience side effects from statins. A new study ...
Jan 17, 2017
0
0
Last week, the Food and Drug Administration proposed banning transfat—partially hydrogenated oil—from restaurants and grocery shelves because it raises bad cholesterol and lowers good cholesterol, contributing to heart ...
Nov 18, 2013
0
0
Two deaths and more than 100 hospitalizations have been linked to a growing health scare in Japan around dietary supplements meant to lower cholesterol, the government said Wednesday.
Mar 27, 2024
0
0
